OMERS ADMINISTRATION Corp Acquires Shares of 45,200 Myomo, Inc. (NYSEAMERICAN:MYO)

OMERS ADMINISTRATION Corp purchased a new stake in Myomo, Inc. (NYSEAMERICAN:MYO) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 45,200 shares of the company’s stock, valued at approximately $291,000. OMERS ADMINISTRATION Corp owned approximately 0.15% of Myomo as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Millennium Management LLC purchased a new stake in Myomo during the 4th quarter worth approximately $780,000. Jefferies Financial Group Inc. acquired a new position in Myomo in the fourth quarter valued at approximately $101,000. Balyasny Asset Management L.P. acquired a new position in Myomo in the fourth quarter valued at approximately $108,000. Bank of America Corp DE lifted its stake in Myomo by 2,516.3% during the fourth quarter. Bank of America Corp DE now owns 48,427 shares of the company’s stock worth $312,000 after purchasing an additional 46,576 shares in the last quarter. Finally, BNP Paribas Financial Markets acquired a new position in Myomo during the fourth quarter worth $64,000. Hedge funds and other institutional investors own 44.99% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently weighed in on MYO shares. HC Wainwright upped their price objective on Myomo from $7.50 to $9.50 and gave the stock a “buy” rating in a research report on Wednesday, March 12th. Ascendiant Capital Markets raised their price objective on Myomo from $9.00 to $11.00 and gave the stock a “buy” rating in a report on Monday, March 17th. Alliance Global Partners reaffirmed a “buy” rating on shares of Myomo in a report on Tuesday, March 11th. Finally, Craig Hallum decreased their target price on shares of Myomo from $11.00 to $10.00 and set a “buy” rating for the company in a research note on Thursday, May 8th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $9.50.

Myomo Stock Performance

Shares of NYSEAMERICAN:MYO opened at $3.42 on Tuesday. The firm has a 50-day moving average price of $4.55. Myomo, Inc. has a 52 week low of $2.76 and a 52 week high of $7.17. The firm has a market capitalization of $103.46 million, a P/E ratio of -14.87 and a beta of 1.68.

Insider Activity

In other news, Director Thomas F. Kirk bought 7,400 shares of the stock in a transaction on Thursday, March 13th. The stock was purchased at an average cost of $5.00 per share, with a total value of $37,000.00. Following the purchase, the director now owns 255,933 shares of the company’s stock, valued at approximately $1,279,665. The trade was a 2.98% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Also, CEO Paul R. Gudonis bought 30,000 shares of the stock in a transaction on Thursday, May 15th. The stock was purchased at an average cost of $3.22 per share, with a total value of $96,600.00. Following the completion of the purchase, the chief executive officer now directly owns 1,051,671 shares in the company, valued at $3,386,380.62. This trade represents a 2.94% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders purchased 126,167 shares of company stock worth $427,093. Company insiders own 4.54% of the company’s stock.

Myomo Company Profile

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.